multiple sclerosis

In the second part, we detected serum NMO-IgG of patients with neuromyelitis optica, multiple sclerosis and health people to verify whether NMO-IgG can be a biomarker for neuromyelitis optica.

第二部神经脊髓炎，多发性硬以及正常人血清进行NMO-IgG定，判断NMO-IgG是否能作为鉴别神经脊髓炎，多发性硬项实验室依据。